Your browser doesn't support javascript.
loading
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial.
Stintzing, Sebastian; Modest, Dominik P; Rossius, Lisa; Lerch, Markus M; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Held, Swantje; Giessen-Jung, Clemens; Moehler, Markus; Jagenburg, Andreas; Kirchner, Thomas; Jung, Andreas; Heinemann, Volker.
Afiliação
  • Stintzing S; Department of Hematology and Oncology, University of Munich, Munich, Germany; DKTK, German Cancer Consortium, German Cancer Research Centre (DKFZ), Heidelberg, Germany. Electronic address: sebastian.stintzing@med.uni-muenchen.de.
  • Modest DP; Department of Hematology and Oncology, University of Munich, Munich, Germany; DKTK, German Cancer Consortium, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Rossius L; Department of Hematology and Oncology, University of Munich, Munich, Germany.
  • Lerch MM; Klinik und Poliklinik für Innere Medizin A, Universitätsmedizin Greifswald, Greifswald, Germany.
  • von Weikersthal LF; MVZ Gesundheitszentrum St. Marien GmbH, Amberg, Germany.
  • Decker T; Studienzentrum Onkologie Ravensburg, Ravensburg, Germany.
  • Kiani A; Klinikum Bayreuth GmbH, Bayreuth, Germany.
  • Vehling-Kaiser U; Praxis Hämatologie/Onkologie/Palliativmedizin-Tagesklinik, Landshut, Germany.
  • Al-Batran SE; Krankenhaus Nordwest, Medizinische Klinik II/Onkologie, Frankfurt, Germany.
  • Heintges T; Lukaskrankenhaus Neuss, Neuss, Germany.
  • Lerchenmüller C; Gemeinschaftspraxis f. Hämatologie u. Onkologie, Münster, Germany.
  • Kahl C; Städtisches Klinikum Magdeburg, Hämatologie/Onkologie, Magdeburg, Germany.
  • Seipelt G; Onkologische Schwerpunktpraxis und Tagesklinik, Bad Soden, Germany.
  • Kullmann F; Klinikum Weiden, Medizinische Klinik I, Weiden, Germany.
  • Stauch M; Praxis für Hämatologie und internistische Onkologie, Kronach, Germany.
  • Scheithauer W; Univ.-Klinik für Innere Medizin I, Klin. Abteilung für Onkologie, Wien, Austria.
  • Held S; ClinAssess GmbH, Leverkusen, Germany.
  • Giessen-Jung C; Department of Hematology and Oncology, University of Munich, Munich, Germany.
  • Moehler M; Universität Mainz, 1. Medizinische Klinik und Poliklinik, Mainz, Germany.
  • Jagenburg A; Radiology Consulting GmbH, Leverkusen, Germany.
  • Kirchner T; Institute of Pathology, University of Munich, Munich, Germany; DKTK, German Cancer Consortium, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Jung A; Institute of Pathology, University of Munich, Munich, Germany; DKTK, German Cancer Consortium, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Heinemann V; Department of Hematology and Oncology, University of Munich, Munich, Germany; DKTK, German Cancer Consortium, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
Lancet Oncol ; 17(10): 1426-1434, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27575024
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Genes ras Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Genes ras Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido